Concepedia

Publication | Closed Access

H<sub>2</sub>ampa─Versatile Chelator for [<sup>203</sup>Pb]Pb<sup>2+</sup>, [<sup>213</sup>Bi]Bi<sup>3+</sup>, and [<sup>225</sup>Ac]Ac<sup>3+</sup>

16

Citations

56

References

2022

Year

Abstract

A new decadentate chelator, H<sub>2</sub>ampa, was designed to be a potential radiopharmaceutical chelator component. The chelator involves both amide and picolinate functional groups on a large non-macrocyclic, ether-bridged backbone. With its large scaffold, H<sub>2</sub>ampa was paired with [<sup>nat/203</sup>Pb]Pb<sup>2+</sup>, [<sup>nat/213</sup>Bi]Bi<sup>3+</sup>, and <sup>nat</sup>La<sup>3+</sup>/[<sup>225</sup>Ac]Ac<sup>3+</sup> ions. Nuclear magnetic resonance spectroscopy and high-resolution mass spectrometry were used to study the non-radioactive metal complexes. A single crystal of [Bi(ampa)](NO<sub>3</sub>) was obtained; its asymmetric, 10-coordinate complex structure was revealed by X-ray diffraction. Optimal conformations of the metal complexes were assessed by density functional theory studies to provide further structural information. Solution studies providing thermodynamic insights into metal complex formation revealed H<sub>2</sub>ampa coordinated Bi<sup>3+</sup>, Pb<sup>2+</sup>, and La<sup>3+</sup> ions to obtain pM values of 26, 14.8, and 15.1, respectively. Preliminary concentration-dependent radiolabeling experiments were carried out between H<sub>2</sub>ampa and three different radiometals to evaluate their compatibility for radiopharmaceutical applications. The chelator radiolabeled [<sup>203</sup>Pb]Pb<sup>2+</sup>, [<sup>213</sup>Bi]Bi<sup>3+</sup>, and [<sup>225</sup>Ac]Ac<sup>3+</sup> in short reaction times (7-30 min), at dilute concentrations, and under mild conditions. Thus, H<sub>2</sub>ampa was proven to be a versatile chelator able to well coordinate a small range of radiometals frequently considered to be alpha therapeutic candidates.

References

YearCitations

Page 1